Literature DB >> 30268819

Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects.

Tanya T Nguyen1, Tomasz Kosciolek2, Yadira Maldonado3, Rebecca E Daly3, Averria Sirkin Martin3, Daniel McDonald2, Rob Knight4, Dilip V Jeste5.   

Abstract

Intestinal microbiome and gut-brain axis have been receiving increasing attention for their role in the regulation of brain/behavior and possible biological basis of psychiatric disorders. Several recent clinical studies have linked the microbiome with neuropsychiatric conditions, although the literature on schizophrenia is quite limited. This study investigated gut microbiome composition in 50 individuals, including 25 persons with chronic schizophrenia and 25 demographically-matched non-psychiatric comparison subjects (NCs). Stool samples were collected and assayed using 16S rRNA sequencing of the V4 region. Examination of unweighted UniFrac and Bray-Curtis dissimilarity revealed significant community-level separation in microbiome composition between the two subject groups. At the phylum level, Proteobacteria were found to be relatively decreased in schizophrenia subjects compared to NCs. At the genus level, Anaerococcus was relatively increased in schizophrenia while Haemophilus, Sutterella, and Clostridium were decreased. Within individuals with schizophrenia, abundance of Ruminococcaceae was correlated with lower severity of negative symptoms; Bacteroides was associated with worse depressive symptoms; and Coprococcus was related to greater risk for developing coronary heart disease. Our findings provide evidence of altered gut microbial composition in persons with chronic schizophrenia and suggest a need for larger and longitudinal studies of microbiome in schizophrenia.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bacteria; Gut-brain axis; Microbes; Phylum; Probiotics; Psychosis

Mesh:

Year:  2018        PMID: 30268819      PMCID: PMC6755901          DOI: 10.1016/j.schres.2018.09.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  53 in total

1.  Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Lisa T Eyler; Rob Knight; Dilip V Jeste
Journal:  J Psychiatr Res       Date:  2018-01-31       Impact factor: 4.791

2.  The gut microbiome composition associates with bipolar disorder and illness severity.

Authors:  Simon J Evans; Christine M Bassis; Robert Hein; Shervin Assari; Stephanie A Flowers; Marisa B Kelly; Vince B Young; Vicky E Ellingrod; Melvin G McInnis
Journal:  J Psychiatr Res       Date:  2016-12-10       Impact factor: 4.791

3.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

4.  Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Cassie R Stallings; Andrea E Origoni; Sunil Khushalani; F Markus Leweke; Faith B Dickerson; Robert H Yolken
Journal:  Schizophr Res       Date:  2013-06-06       Impact factor: 4.939

5.  Correlates of self-rated successful aging among community-dwelling older adults.

Authors:  Lori P Montross; Colin Depp; John Daly; Jennifer Reichstadt; Shahrokh Golshan; David Moore; David Sitzer; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2006-01       Impact factor: 4.105

6.  Abnormalities in chemokine levels in schizophrenia and their clinical correlates.

Authors:  Suzi Hong; Ellen E Lee; Averria Sirkin Martin; Benchawanna Soontornniyomkij; Virawudh Soontornniyomkij; Cristian L Achim; Chase Reuter; Michael R Irwin; Lisa T Eyler; Dilip V Jeste
Journal:  Schizophr Res       Date:  2016-09-17       Impact factor: 4.939

Review 7.  Insights into the role of the microbiome in obesity and type 2 diabetes.

Authors:  Annick V Hartstra; Kristien E C Bouter; Fredrik Bäckhed; Max Nieuwdorp
Journal:  Diabetes Care       Date:  2015-01       Impact factor: 19.112

Review 8.  The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.

Authors:  David N O'Dwyer; Robert P Dickson; Bethany B Moore
Journal:  J Immunol       Date:  2016-06-15       Impact factor: 5.422

Review 9.  The microbiome and cancer.

Authors:  Robert F Schwabe; Christian Jobin
Journal:  Nat Rev Cancer       Date:  2013-10-17       Impact factor: 60.716

10.  UniFrac: a new phylogenetic method for comparing microbial communities.

Authors:  Catherine Lozupone; Rob Knight
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

View more
  43 in total

Review 1.  Inflammation in Mental Disorders: Is the Microbiota the Missing Link?

Authors:  Sophie Ouabbou; Ying He; Keith Butler; Ming Tsuang
Journal:  Neurosci Bull       Date:  2020-06-27       Impact factor: 5.203

2.  Integrative Review of Gut Microbiota and Expression of Symptoms Associated With Neonatal Abstinence Syndrome.

Authors:  Stephanie D Sealschott; Rita H Pickler; Christine A Fortney; Michael T Bailey
Journal:  Nurs Res       Date:  2020 Sep/Oct       Impact factor: 2.381

Review 3.  Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes.

Authors:  Jamie M Joseph; Catrin Law
Journal:  Neurosci Biobehav Rev       Date:  2018-11-22       Impact factor: 8.989

Review 4.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

5.  Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.

Authors:  Michael Maes; Sunee Sirivichayakul; Buranee Kanchanatawan; Aristo Vodjani
Journal:  Neurotox Res       Date:  2019-05-10       Impact factor: 3.911

6.  Aging-related changes in fluid intelligence, muscle and adipose mass, and sex-specific immunologic mediation: A longitudinal UK Biobank study.

Authors:  Brandon S Klinedinst; Colleen Pappas; Scott Le; Shan Yu; Qian Wang; Li Wang; Karin Allenspach-Jorn; Jonathan P Mochel; Auriel A Willette
Journal:  Brain Behav Immun       Date:  2019-09-09       Impact factor: 7.217

7.  Gut microbes in neurocognitive and mental health disorders.

Authors:  Tyler Halverson; Kannayiram Alagiakrishnan
Journal:  Ann Med       Date:  2020-08-31       Impact factor: 4.709

Review 8.  Cognitive complications of cancer and cancer-related treatments - Novel paradigms.

Authors:  Naomi Lomeli; Javier Lepe; Kalpna Gupta; Daniela A Bota
Journal:  Neurosci Lett       Date:  2021-02-11       Impact factor: 3.046

9.  Maternal dietary omega-3 deficiency worsens the deleterious effects of prenatal inflammation on the gut-brain axis in the offspring across lifetime.

Authors:  Q Leyrolle; F Decoeur; G Briere; C Amadieu; A R A A Quadros; I Voytyuk; C Lacabanne; A Benmamar-Badel; J Bourel; A Aubert; A Sere; F Chain; L Schwendimann; B Matrot; T Bourgeois; S Grégoire; J G Leblanc; A De Moreno De Leblanc; P Langella; G R Fernandes; L Bretillon; C Joffre; R Uricaru; P Thebault; P Gressens; J M Chatel; S Layé; A Nadjar
Journal:  Neuropsychopharmacology       Date:  2020-08-11       Impact factor: 7.853

10.  Gut microbiome in Schizophrenia: Altered functional pathways related to immune modulation and atherosclerotic risk.

Authors:  Tanya T Nguyen; Tomasz Kosciolek; Rebecca E Daly; Yoshiki Vázquez-Baeza; Austin Swafford; Rob Knight; Dilip V Jeste
Journal:  Brain Behav Immun       Date:  2020-10-22       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.